Brijjit for Wound Closure in Gender Affirming Mastectomies

Brief description of study

The purpose of this study is to evaluate the use of Brijjit® devices for wound closure following gender-affirming mastectomy. Brijjit® is a non-invasive wound closure device already used by our providers as part of standard care in a variety of clinical situations. It is part of a class of devices called Force-Modulating Tissue Bridges (FMTBs), which are adhesive products that have an additional support component to relieve tension at the wound site. The researchers are interested in evaluating whether the Brijjit® device is superior to usage of Steri-strips (thin adhesive bandages), which are typically used for patients undergoing gender-affirming mastectomies.


Clinical Study Identifier: s22-00304
ClinicalTrials.gov Identifier: NCT05368519
Principal Investigator: Rachel Bluebond-Langner.
Other Investigator: William Jacob Rifkin.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.